Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 3,569 | 6,371 | 3,035 | 2,820 | 2,010 |
| Operating Income | -3,569 | -6,371 | -3,035 | -2,820 | -2,010 |
| Interest Expense | 0 | 4 | 0 | 2 | 1 |
| Other Income | 4 | 0 | 0 | 279 | 0 |
| Pre-tax Income | -3,565 | -6,375 | -3,035 | -2,543 | -2,011 |
| Net Income Continuous | -3,565 | -6,182 | -3,035 | -2,543 | -2,011 |
| Net Income | $-3,565 | $-6,182 | $-3,035 | $-2,543 | $-2,011 |
| EPS Basic Total Ops | -101.44 | -192.44 | -102.07 | -122.41 | -97.21 |
| EPS Basic Continuous Ops | -101.55 | -191.37 | -101.93 | -122.63 | -98.38 |
| EPS Diluted Total Ops | -101.44 | -192.44 | -102.07 | -122.41 | -97.21 |
| EPS Diluted Continuous Ops | -101.55 | -191.37 | -101.93 | -122.63 | -98.38 |
| EBITDA(a) | $-3,559 | $-2,322 | $-3,024 | $-2,807 | $-2,000 |